Suzhou Ribo Life Science Co., Ltd. (HKG:6938)

Suzhou Ribo Life Science Revenue

Suzhou Ribo Life Science had revenue of 419.74M CNY in the half year ending June 30, 2026, with 533.04% growth. This brings the company's total for the last twelve months to 464.43M, up 157.83% year-over-year. In the year 2025, Suzhou Ribo Life Science had annual revenue of 148.51M with 4.12% growth. That makes Suzhou Ribo Life Science the 25,644th largest company in the world by revenue and 1,514th in Hong Kong.

• Revenue (ttm): 464.43M CNY
• Revenue Growth: +157.83%
• P/S Ratio: 13.96
• Revenue / Employee: 1.03M CNY
• Employees: 453
• Market Cap: 7.56B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Overseas 105.41M 71.0%
• Mainland China 43.10M 29.0%

Fiscal year ended Dec 31, 2025 See the full Suzhou Ribo Life Science breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	148.51M	5.88M	4.12%
Dec 31, 2024	142.63M	142.58M	324,052.27%
Dec 31, 2023	44.00K	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 9, 2026

Data Sources Report a data error